- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04700462
COVID-19 Preventive Behavior in African Americans
2. november 2021 opdateret af: Johns Hopkins University
Optimizing Tailored-feedback Message to Promote Adherence Behavior to Prevent COVID-19 in African Americans
The Center Disease Control has published a set of guidelines to contain the spread of the virus, since it is known to spread from person-to-person.
Given the vaccine and specific antiviral treatment for Coronavirus disease (COVID-19) remain under development and will take months or years to develop, intermittent and sustained preventive behaviors may be needed into 2022 unless effective treatments or vaccines are developed.
Thus, effectively implementing preventive behaviors remains a critical step in bringing the pandemic under long-term control.
Leveraging the ecological momentary assessment (EMA) method developed in the parent R01 for smartphones, which allows for real-time data collection on individual's behaviors, the investigators propose a prospective single arm and longitudinal study to examine the effectiveness of self-monitoring EMA (SM-EMA) in promoting adherence to COVID-19 preventative behaviors.
SM-EMA users will download the smartphone app which includes: (1) instructional videos to provide knowledge of preventative behaviors; (2) self-monitoring of preventative behaviors during intervention and follow-up phases; (3) tailored-feedback messages to encourage preventative behaviors; and (4) mobile-enabled website to provide an interactive learning platform.
If proven efficacious, this intervention could be efficiently disseminated to reach the larger public and foster preventive behaviors into self-management as effective strategies for long-term control of the COVID-19 pandemic.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Given the vaccine and specific antiviral treatment for COVID-19 will take months or years to develop and finalize, preventive behaviors remain the most effective strategy thus far and may be needed until 2022 to control the pandemic.
African Americans, who have 3-fold higher infection rate and 6-fold higher death rate compared to the white counterparts, are an especially vulnerable population to COVID-19.
Immediately initiating a project that promotes and maximizes adherence to preventative behaviors is vital to addressing the ongoing COVID-19 pandemic.
The investigators propose a prospective single arm and longitudinal study to examine the effectiveness of SM-EMA in promoting adherence to COVID-19 preventative behaviors.
The intervention will include two daily pop-up messages during Week 1 (one in the morning and one in the afternoon), one daily pop-message in Week 2, and two pop-up messages a week in Weeks 3 and 4. The duration for the intervention will be four weeks.
The study outcomes will be collected at baseline (pre-intervention, T1), post-(completion of the intervention, T2, primary endpoint), and monthly follow-up for three months (T3-T5).
The total study duration will be four months.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
250
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21205
- Johns Hopkins School of Nursing
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
60 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- African American aged 60 or older
- Able to read and write English
- Willing to commit to use the smartphone app with the pop-up messages and then four follow-up surveys (total four months).
Exclusion Criteria:
- No children or others aged 59 years or younger
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Sm-EMA
Participants will receive the Self-monitoring ecological momentary assessment behavior change tool.
|
Self-monitoring ecological momentary assessment behavior change tool to promote adherence to a desired behavior (i.e.
COVID-19 preventative behaviors).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Knowledge Test score as assessed by a questionnaire
Tidsramme: Pre-intervention, Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
It is a measure of one's knowledge of COVID-19 preventative behaviors, with a score range of 0-18, higher scores indicating better knowledge.
|
Pre-intervention, Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
|
Change in Self-efficacy as assessed by self-efficacy questionnaire
Tidsramme: Pre-intervention, Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
It is a measure of one's belief that they will be successful in reaching a behavior goal, with 6-items of questionnaire, with a score of 0-60, higher score indicating higher level of self-efficacy.
|
Pre-intervention, Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
|
Change in preventive Behavior Score
Tidsramme: Pre-intervention, Daily during intervention week 1 and bi-weekly during intervention weeks 3-4, Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
It is a measure of one's adherence to COVID-19 preventative behaviors, with a score range 0-18, higher score indicating worsening preventive behaviors.
|
Pre-intervention, Daily during intervention week 1 and bi-weekly during intervention weeks 3-4, Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
|
Change in System Usability Scale (SUS) score
Tidsramme: Immediately Post-intervention
|
It is used to assess the global view of the participant's assessment about usability of SM-EMA, with a score of 1-7, higher score indicting more useable for the app.
|
Immediately Post-intervention
|
|
Change in Global Impression of Change as assessed by a questionnaire
Tidsramme: Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
It is a single item used to assess the participant's perceived behavior change, with a score of 1-7, higher score indicating better global impression of change.
|
Immediately Post-intervention, 1, 2, and 3 months Post-intervention
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Chao Hsing Yeh, PhD, Johns Hopkins School of Nursing
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
5. februar 2021
Primær færdiggørelse (Faktiske)
30. oktober 2021
Studieafslutning (Faktiske)
30. oktober 2021
Datoer for studieregistrering
Først indsendt
6. januar 2021
Først indsendt, der opfyldte QC-kriterier
6. januar 2021
Først opslået (Faktiske)
7. januar 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
3. november 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
2. november 2021
Sidst verificeret
1. januar 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IRB00250644
- 3R01AG056587-03S1 (U.S. NIH-bevilling/kontrakt)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Covid19
-
Anavasi DiagnosticsIkke rekrutterer endnu
-
Ain Shams UniversityRekruttering
-
Israel Institute for Biological Research (IIBR)Afsluttet
-
Colgate PalmoliveAfsluttet
-
Christian von BuchwaldAfsluttet
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdAktiv, ikke rekrutterende
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichTilmelding efter invitation
-
Alexandria UniversityAfsluttet
-
Henry Ford Health SystemAfsluttet
Kliniske forsøg med Sm-EMA
-
Click Therapeutics, Inc.AfsluttetCovid19 | Stress | Stress, psykologisk | EnsomhedForenede Stater
-
Northeastern UniversityNational Center for Advancing Translational Sciences (NCATS)Afsluttet
-
Massachusetts General HospitalBoston UniversityRekrutteringSkizofreni | PsykoseForenede Stater
-
The University of Hong KongAktiv, ikke rekrutterende
-
University Hospital, MontpellierCentre Hospitalier Universitaire de Nīmes; Instituto de Investigación Sanitaria... og andre samarbejdspartnereRekrutteringSelvmordstanker | Selvmordsadfærd | Personlig historie om en nylig selvmordskriseFrankrig, Spanien
-
The University of Hong KongRekruttering
-
Columbia UniversityChildren's Hospital of Philadelphia; American Foundation for Suicide PreventionTilmelding efter invitationSelvmordstanker | SelvmordsadfærdForenede Stater
-
University of WashingtonNational Institute of Mental Health (NIMH)RekrutteringSelvmordstanker | SelvskadeForenede Stater
-
University Hospital Inselspital, BerneImaCor, Inc.Afsluttet
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)AfsluttetGenopretning | Stofbrugsforstyrrelse (SUD)Forenede Stater